Sigma-Aldrich Asks Court to Reject Open Biosystems' Request to Dismiss IP Suit | GenomeWeb
Sigma-Aldrich last week moved to keep its patent-infringement lawsuit against Open Biosystems in play, filing with a US District Court proposed arguments defending its desire to allow the case to proceed.
 
The filing was in response to an Open Biosystems motion made earlier this month asking the court to dismiss the litigation on the grounds that Sigma-Aldrich did not have “all substantial rights” to the intellectual property in question, and therefore was not in a position to file the suit.
 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.